A股異動 | 智雲股份高開直線漲停 控股股東擬轉讓股份引入戰投
格隆匯12月12日丨智雲股份(300097.SZ)盤初高開直線漲停,現報9.37元,暫成交6376萬元,最新總市值27億元。

智雲股份昨晚公告,控股股東擬轉讓7.16%公司股份,為智雲股份引入戰投。本次協議轉讓股份的每股轉讓價7.79元,智雲股份12月11日的收盤價為8.52元,轉讓價格較最新收盤價格折價8.57%。
值得注意的是,智雲股份的三季報由盈轉虧,傳統產品市場需求增速放緩。且近期公司的股價表現也不如人意。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.